Faculty Disclosures
| M. F. Beal, MD |
No disclosure on file
|
| Jeffery Vance, MD, PhD |
Dr. Vance has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for neurology genetics. |
| Janet L. Oblinger |
No disclosure on file
|
|
No disclosure on file
|
| Zarife Sahenk, MD, PhD, FAAN |
Dr. Sahenk has nothing to disclose. |
| Dominique Bonneau |
No disclosure on file
|
| Catarina Quinzii Hirano, MD |
No disclosure on file
|
| Leonardo Salviati, MD |
No disclosure on file
|
| Carlos A. Luciano, MD, FAAN |
Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Akcea Pharmaceuticals. Dr. Luciano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for SIMED. Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Universal Insurance Co.. Dr. Luciano has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pueblo Supermarket. The institution of Dr. Luciano has received research support from National Institutes of Health. The institution of Dr. Luciano has received research support from Catalyst Pharmaceuticals. Dr. Luciano has received personal compensation in the range of $100,000-$499,999 for serving as a Professor and Chair with University of Puerto Rico. |
| Rocco Liguori, MD |
Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HEALTHWARE GROUP s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION PHARMA ITALY s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME CORPORATION . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ECM NETWORK s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ALEXION PHARMA ITALY s.r.l.. Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PTS s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ALEXION PHARMA ITALY s.r.l.. Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AIM EDUCATION s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MAYA IDEE SUD s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ISTITUTO SUPERIORE DI SANITA' . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for QbGROUP s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SYMPOSIUM s.r.l. . Dr. Liguori has received publishing royalties from a publication relating to health care. |
| Alessandra Baracca |
No disclosure on file
|
| Luis Lopez |
No disclosure on file
|
| Alessandro Filla, MD, FAAN |
No disclosure on file
|
| Beatriz Dorado |
No disclosure on file
|
| Valerio Carelli, MD, PhD |
Dr. Carelli has received personal compensation in the range of $0-$499 for serving as a Consultant for Chiesi Farmaceutici. Dr. Carelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi Farmaceutici. |
| Patrizia Amati-Bonneau |
No disclosure on file
|
| Salvatore DiMauro, MD |
No disclosure on file
|
| Corrado Angelini, MD, FAAN |
Dr. Angelini has nothing to disclose. |
| Giuliana Galassi, MD |
No disclosure on file
|
| Nicholas W. Wood |
No disclosure on file
|
| Massimo Zeviani, MD, PhD |
No disclosure on file
|
| Chiara Criscuolo |
No disclosure on file
|
| Barry Snow, MD, BchB |
No disclosure on file
|
| Eduardo Bonilla, MD |
No disclosure on file
|
| Antonella Spinazzola, MD |
No disclosure on file
|
| Oliver E. Bandmann, MD, PhD, FAAN |
No disclosure on file
|
| Marco Onofrj, MD |
Dr. Onofrj has nothing to disclose. |
| Jorida Coku |
No disclosure on file
|
| Daita Kaneda, MD |
No disclosure on file
|
| Michio Hirano, MD, FAAN |
Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Biosciences. Dr. Hirano has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Communication. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Envision Communications. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for 好色先生. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Cure SMA. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Muscular Dystrophy Association. The institution of Dr. Hirano has received research support from UCB. The institution of Dr. Hirano has received research support from Cyclerion. Dr. Hirano has received research support from Reneo Pharmaceuticals. The institution of Dr. Hirano has received research support from Astellas. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received personal compensation in the range of $0-$499 for serving as a Study Section Reviewer with NIH. Dr. Hirano has a non-compensated relationship as a Research Advisory Board member with Muscular Dystrophy Association that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific and Medical Advisory Board member with United Mitochondrial Disease Foundation that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific Advisory Board member with Barth Syndrome Foundation that is relevant to AAN interests or activities. |
| Subramaniam Sriram, MD |
Dr. Sriram has nothing to disclose. |
| Derek Narendra, MD |
The institution of Dr. Narendra has received research support from National Institutes of Health. |
| Christophe Verny |
No disclosure on file
|
| Clifford J. Beall, PhD |
No disclosure on file
|
| Maya Vila |
No disclosure on file
|
| Ichizo Nishino, MD, PhD, FAAN |
The institution of Dr. Nishino has received research support from AMED. |
| Sara Shanske, PhD |
No disclosure on file
|
| Pierre Labauge, MD |
Dr. Labauge has nothing to disclose. |
| K. Reed Clark, PhD |
No disclosure on file
|
| Tomonobu Kato |
No disclosure on file
|
| Marco Spinazzi, MD, PhD |
No disclosure on file
|
| Chiara La Morgia, MD |
Dr. La Morgia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regulatory Pharmanet s.r.l. . Dr. La Morgia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Santhera Pharmaceuticals. Dr. La Morgia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chiesi Farmaceutici s.p.a.. The institution of Dr. La Morgia has received research support from Italian Ministry of Health. |
| Fang Fang |
No disclosure on file
|
| Heng Du |
No disclosure on file
|
| Siddharama Pawate, MD |
The institution of Dr. Pawate has received research support from Genentech. The institution of Dr. Pawate has received research support from Biogen. |
| Alain Furby |
No disclosure on file
|
| Valeria Tiranti |
No disclosure on file
|
| Mahsa Mehrazin, MD |
No disclosure on file
|
| Marc C. Patterson, MD, FRACP, FAAN |
Dr. Patterson has received personal compensation for serving as an employee of IntraBio. The institution of Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphazyme /KemPharm/Zevra. Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azafaros. Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IntraBio. Dr. Patterson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage. Dr. Patterson has stock in IntraBio. The institution of Dr. Patterson has received research support from Glycomine. The institution of Dr. Patterson has received research support from Orphazyme /KemPharm/Zevra. The institution of Dr. Patterson has received research support from Idorsia. The institution of Dr. Patterson has received research support from Shire-Takeda. Dr. Patterson has received publishing royalties from a publication relating to health care. Dr. Patterson has received publishing royalties from a publication relating to health care. |
| Michelle P. Lin, CRC |
Dr. Lin has nothing to disclose. |
| Claire F. Wardell |
No disclosure on file
|
| Ali M. Alqahtani |
No disclosure on file
|
| Nawaf A. Alqahtani |
No disclosure on file
|
| Paul Gilbert, PhD |
Dr. Gilbert has nothing to disclose. |
| Andrew Herndon |
No disclosure on file
|
| Sarah A. Morrow, MD, MSC, FRCPC, FAAN |
Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIogen Idec. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono/Merck. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SanofiGenzyme. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Morrow has received research support from Celgene. |
| Santiago M. Pagano Ajolfi, Sr., MD |
No disclosure on file
|
| Mikio Shoji, MD |
No disclosure on file
|
| Ameera Haque |
No disclosure on file
|
| Stephen J. Howell, BS, EMT-B |
Mr. Howell has nothing to disclose. |
| Takumi Nakamura, MD |
No disclosure on file
|
| Ryan P. Renn |
No disclosure on file
|